Gilead committed to having clinical data ready for a low-dose TAF based regimen for children 2-12 years by late 2018/early 2019.
Gilead
Sub-Actions & Milestones

Having clinical data ready for a low-dose TAF based regimen for children 2-12 years by late 2018/early 2019.

-

-

-

-

-

-

-

-

-

-

-

Updates

-

Updates

Notes

Responsible